Is a $28 Billion AI IPO Trading at Just 7x Earnings?
A $28 billion AI hardware IPO is trading at about 7x forward earnings, sparking a heated debate: is it a disrupted, d...
When To Use Stop Loss Or Take Profit Crypto
When To Use Stop Loss Or Take Profit Crypto explains the practical moments to deploy each tool, helping you manage risk without overtrading.
22,240 articles
Single Biggest Opportunity Texas: TI Pre-Earnings Rally Set
Texas Instruments preps for July earnings with a guidance-led breakout in industrial and data-center demand, plus a f...
Hospital Systems Dropping Medicare Threatens Medicare Plans
A wave of mid contract terminations by hospital systems is reshaping Medicare Advantage. Investors and patients confr...
Altman Dario Amodei Refused Handshake at AI Summit
OpenAI CEO Sam Altman and Anthropic CEO Dario Amodei avoided a handshake at the India AI Impact Summit, signaling a w...
Asian Stocks Just Beat S&P as Asian ETFs Rally in 2026
Early 2026 shows Asia-led gains outpacing the U.S., with Asia-focused ETFs rising as tech and earnings momentum impro...
Scream 7 Rides Millennial Nostalgia to Box Office Win
'scream 7' opened with a $64.1 million domestic debut, the year’s best start and a clear sign that millennial nostalg...
Costco Earnings Scorecard: Solid Beat Signals Steady Growth
Costco posted a clean second-quarter beat, with revenue near $69.6B and EPS of $4.58, as memberships rise and digital...
Oracle Price Target $240 Sparks AI Cloud Rally Today
Analysts raise the oracle price target $240 after Oracle reports resilient AI cloud demand and stronger-than-expected...
Iran Supertanker Pushes Through Strait as Markets React
A large Iranian-linked vessel crossed the Strait of Hormuz, with several others following in a week of heightened sec...
Microsoft’s Worst Start Since 2008: Buy the Dip?
Microsoft kicks off 2026 with a rough start as earnings beat clashes with a surge in capital expenditures. Traders de...
TJX Hits $60B Revenue, Missed Memo Just Billion Moment
TJX shattered a retail milestone by exceeding $60 billion in annual revenue for the first time, signaling enduring st...
Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status